# ClinicalTrials.gov record NCT05912621

> PeptideScanner retained ClinicalTrials.gov record NCT05912621 at 2026-07-30T18:37:14.695Z. Its registry update date was 2024-12-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct05912621-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-12-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05912621-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05912621-tirzepatide-v1.json
- Content SHA-256: `69658cc4f2e755fc25247fef714566f1b7038b980c55433b8e8d8bae903b4889`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05912621 ([`ctg-observation-nct05912621-2024-12-04-b3a8034cf873`](#source-ctg-observation-nct05912621-2024-12-04-b3a8034cf873))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05912621 at 2026-07-30T18:37:14.695Z. Its registry update date was 2024-12-04, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct05912621-2024-12-04-b3a8034cf873`](#source-ctg-observation-nct05912621-2024-12-04-b3a8034cf873))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05912621 at 2026-07-30T18:37:14.695Z. Its registry update date was 2024-12-04, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct05912621-2024-12-04-b3a8034cf873`](#source-ctg-observation-nct05912621-2024-12-04-b3a8034cf873))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05912621-2024-12-04-b3a8034cf873`](#source-ctg-observation-nct05912621-2024-12-04-b3a8034cf873))

## Sources

<a id="source-ctg-observation-nct05912621-2024-12-04-b3a8034cf873"></a>
- **ClinicalTrials.gov record NCT05912621 · retained source version 2024-12-04:b3a8034cf873b7a28d167ad6c499777901357e39df21578316b822bdb6ca47a7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05912621) (`ctg-observation-nct05912621-2024-12-04-b3a8034cf873`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05912621." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05912621-tirzepatide-v1.json SHA-256: 69658cc4f2e755fc25247fef714566f1b7038b980c55433b8e8d8bae903b4889.